CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Spencer Platt The Health Care sector was one to generally avoid in 2023. Unless you were significantly overweight (no pun intended) in shares of Eli Lilly (LLY) and Novo Nordisk (NVO), it’s probable that you underperformed the S&P 500 given the Health Care Select Sector SPDR ETF’s (XLV) weak returns. Has the tide turned in favor of defensive Health Care equities? XLV has beaten SPY by about five percentage points just since mid-December.  I see more upside ahead in CVS Health (NYSE:CVS). Following guida ...